跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,218 条关于
“PKP2-associated ARVC”
全部
21,218
临床试验
10,276
药物
469
机构
111
资讯
10,362
前天
FDA Grants RMAT Designation to Tenaya's TN-401 Gene Therapy for PKP2-Associated ARVC
去年
Tenaya Therapeutics Secures $8M CIRM Grant to Advance Gene Therapy Trial for Rare Heart Condition
9个月前
Tenaya Therapeutics Reports Promising Early Results for TN-401 Gene Therapy in Rare Heart Disease
去年
Tenaya Therapeutics Doses First Patient in Phase 1b Trial of TN-401 Gene Therapy for ARVC
去年
Tenaya Therapeutics' TN-201 Shows Promise in Early Hypertrophic Cardiomyopathy Trial
9个月前
Tenaya Therapeutics Reports Positive Gene Therapy Data for Rare Heart Disease Despite Stock Decline Following $60M Offering
去年
Tenaya Therapeutics Doses First Patient in Cardiac Gene Therapy Trial for ARVC
去年
AMO Pharma Launches Largest-Ever Clinical Trial for Rare Heart Condition ARVC with GSK3β Inhibitor AMO-02
去年
Rocket Pharmaceuticals Advances Gene Therapy Pipeline with Key Updates on Danon Disease and PKP2-ACM Programs
去年
Rocket Pharmaceuticals to Present First Phase 1 Data for Gene Therapy in Rare Heart Condition at ASGCT
第 1 页,共 1037 页
上一页
下一页